Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 48
Filter
Add more filters

Complementary Medicines
Publication year range
1.
BMC Musculoskelet Disord ; 23(1): 987, 2022 Nov 16.
Article in English | MEDLINE | ID: mdl-36384557

ABSTRACT

BACKGROUND: Temporomandibular joint osteoarthritis (TMJOA) is characterized by abnormal subchondral bone remodeling and cartilage degeneration. As a non-invasive biophysical technology, pulsed electromagnetic field (PEMF) treatment has been proven to be efficient in promoting osteogenesis. However, the potential bone protective effect and mechanism of PEMF on abnormal subchondral bone remodeling in TMJOA are unknown. METHODS: Unilateral anterior crossbite (UAC) was used to create TMJOA model in rats, and 17ß-estradiol (E2) were injected daily to mimic patients with high-physiological levels of estrogen. Mouse osteoblast-like MC3T3-E1 cells treated with recombinant murine IL-1ß was used to establish inflammatory environment in vitro. The treatment group were subjected to PEMF (2.0mT, 15 Hz, 2 h/d). Micro-CT scanning, histological staining, real-time PCR and western blotting assays were preformed to observe the changes in the subchondral bone. RESULTS: Abnormal resorption of subchondral bone induced by UAC, characterized by decreased bone mineral density, increased osteoclast activity and expression of osteoclast-related factors (RANKL) and down-regulated expression of osteogenesis-related factors (OPG, ALP, Runx2 and OCN) at the early stage, could be reversed by PEMF exposure, which was similar to the effect of estrogen. In addition, PEMF exposure and E2 supplement may have a synergistic effect to some extent. Moreover, PEMF exposure could promote the ALP activity and osteogenic mineralization ability of MC3T3-E1 cells. PEMF promoted the expression of factors related to Wnt/ß-Catenin signal pathway both in vivo and in vitro. CONCLUSIONS: Appropriate PEMF exposure have a protective effect on subchondral bone in TMJOA at early stage, in which canonical Wnt/ß-Catenin pathway may be involved. PEMF may be a promising biophysical approach for early intervention of TMJOA in clinic.


Subject(s)
Electromagnetic Fields , Osteoarthritis , Rats , Mice , Animals , beta Catenin , Bone Remodeling , Temporomandibular Joint/diagnostic imaging , Temporomandibular Joint/pathology , Osteoarthritis/pathology , Estrogens
2.
J Photochem Photobiol B ; 222: 112281, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34388640

ABSTRACT

Photobiomodulation (PBM) has been applied as a non-invasive technique for treating temporomandibular joint symptoms, especially on painful condition's relief, however the anti-inflammatory mechanism underlying the effect of PBM remains uncertain. This study aims to evaluate the mechanisms of action of PBM (808 nm) in a carrageenan-induced inflammation on temporomandibular joint (TMJ) of rats. In this study male Wistar rats were pre-treated with irradiation of a low-power diode laser for 15 s on TMJ (infra-red 808 nm, 100 mW, 50 J/cm2 and 1.5 J) 15 min prior an injection in the temporomandibular joint of carrageenan (100 µg/TMJ). 1 h after the TMJ treatments, the rats were terminally anesthetized for joint cavity wash and periarticular tissues collect. Samples analysis demonstrated that PBM inhibit leukocytes chemotaxis in the TMJ and significantly reduces amounts of TNF-α, IL-1ß and CINC-1. In addition, Western blotting analysis demonstrated that PBM significantly decreased the protein levels of P2X3 and P2X7 receptors in the periarticular tissues. On the other hand, PBM was able to increase protein level of IL-10 (anti-inflammatory cytokine). In summary, it is possible to suggest that PBM inhibit inflammatory chemotaxis, modulation the balance of the pro- and anti-inflammatory characteristics of inflammatory cells.


Subject(s)
Inflammation/therapy , Lasers, Semiconductor/therapeutic use , Low-Level Light Therapy , Temporomandibular Joint/radiation effects , Animals , Carrageenan/toxicity , Cell Movement/radiation effects , Down-Regulation/radiation effects , Enzyme-Linked Immunospot Assay , Inflammation/chemically induced , Interleukin-10/analysis , Leukocytes/cytology , Leukocytes/metabolism , Male , Rats , Rats, Wistar , Receptors, Purinergic P2X3/metabolism , Receptors, Purinergic P2X7/metabolism , Temporomandibular Joint/metabolism , Temporomandibular Joint/pathology , Tumor Necrosis Factor-alpha/analysis
3.
Sci Rep ; 11(1): 14638, 2021 07 19.
Article in English | MEDLINE | ID: mdl-34282199

ABSTRACT

Hypertonic dextrose prolotherapy (DPT) has been reported to be effective for temporomandibular disorders (TMDs) in clinical trials but its overall efficacy is uncertain. To conduct a systematic review with meta-analysis of randomized controlled trials (RCTs) to synthesize evidence on the effectiveness of DPT for TMDs. Eleven electronic databases were searched from their inception to October, 2020. The primary outcome of interest was pain intensity. Secondary outcomes included maximum inter-incisal mouth opening (MIO) and disability score. Studies were graded by "Cochrane risk of bias 2" tool; if data could be pooled, a meta-analysis was performed. Ten RCTs (n = 336) with some to high risk of bias were included. In a meta-analysis of 5 RCTs, DPT was significantly superior to placebo injections in reducing TMJ pain at 12 weeks, with moderate effect size and low heterogeneity (Standardized Mean Difference: - 0.76; 95% CI - 1.19 to - 0.32, I2 = 0%). No statistically significant differences were detected for changes in MIO and functional scores. In this systematic review and meta-analysis, evidence from low to moderate quality studies show that DPT conferred a large positive effect which met criteria for clinical relevance in the treatment of TMJ pain, compared with placebo injections.Protocol registration at PROSPERO: CRD42020214305.


Subject(s)
Glucose/administration & dosage , Prolotherapy , Temporomandibular Joint Disorders/drug therapy , Adolescent , Adult , Female , Glucose Solution, Hypertonic/administration & dosage , Humans , Injections, Intra-Articular , Male , Middle Aged , Pain/drug therapy , Pain/epidemiology , Pain Management/methods , Pain Management/statistics & numerical data , Prolotherapy/methods , Randomized Controlled Trials as Topic/statistics & numerical data , Temporomandibular Joint/drug effects , Temporomandibular Joint/pathology , Temporomandibular Joint Disorders/epidemiology , Treatment Outcome , Young Adult
4.
Ann N Y Acad Sci ; 1503(1): 48-59, 2021 11.
Article in English | MEDLINE | ID: mdl-33759195

ABSTRACT

Macrophage-mediated regulation of chondrocytes plays an important role in promoting temporomandibular joint (TMJ) inflammation. We investigated whether extracellular vesicles (EVs) derived from M1 macrophages (M1-EVs) have a proinflammatory effect on TMJ inflammation and what the associated mechanisms are. In vitro, purified THP-1 cell-derived M1-EVs were applied to human TMJ condylar chondrocytes, and in vivo M1-EVs derived from bone marrow-derived macrophages (BMDMs) were injected into rat TMJs. The levels of IL-6, IL-8, IL-1ß, and matrix metalloproteinase were then evaluated and found to be upregulated in the chondrocytes and rat TMJs. MicroRNA sequencing analysis was performed to identify differential expression of miRNAs, including miR-1246. High expression of miR-1246 in M1-EVs from synovial fluid of patients with TMJ osteoarthritis and synovitis was verified by RT-PCR. We then identified miR-1246 targets GSK3ß and Axin2 and found that miR-1246 inhibits GSK3ß and Axin2 expression, causing activation of the Wnt/ß-catenin pathway and inflammation in condylar chondrocytes. Our study found that M1-EVs promote inflammation by transfer of miR-1246 to condylar chondrocytes, thus providing new insight into one mechanism that can promote TMJ inflammation.


Subject(s)
Arthritis/etiology , Arthritis/metabolism , Extracellular Vesicles/metabolism , Macrophages/metabolism , MicroRNAs/genetics , Temporomandibular Joint/pathology , Wnt Signaling Pathway , Arthritis/pathology , Biomarkers , Cytokines/metabolism , Disease Susceptibility , Gene Expression Regulation , Humans , Inflammation Mediators , Macrophage Activation/genetics , Macrophage Activation/immunology , Macrophages/immunology
5.
J Manipulative Physiol Ther ; 43(8): 806-815, 2020 10.
Article in English | MEDLINE | ID: mdl-32893024

ABSTRACT

OBJECTIVE: The purpose of this study was to assess the effects of 4-week protocol of diacutaneous fibrolysis (DF) compared with simulated DF (sham-DF) on myalgia and mouth opening. METHODS: In a sham randomized controlled trial, 34 women with temporomandibular disorders and myofascial pain were randomly divided as intervention group (IG) and sham-DF group (SG). The IG received 4 weeks of real DF, and the SG received sham. Pain was assessed through the visual analog scale and pressure pain thresholds (PPTs) on the temporomandibular joint (TMJ), and over the temporal and masseter muscles. The Mandibular Function Impairment Questionnaire was used to classify the participants regarding to the severity of the functional limitation related to TMD. RESULTS: Pain scores decreased for both groups, but the IG showed lower values at week 4, with between-group differences. Bilateral temporal PPT showed higher values at week 4, with between-group differences. The SG had lower PPTs but the IG had higher PPTs, both compared to baseline results. The time-by-group interaction and the frequency of participants above 40 mm of mouth opening showed a significant difference for the IG over time with higher results at the 4-week assessment compared to its own baseline. Both groups showed lower MFIQ scores from baseline to 4-week assessment. There was a lower frequency of a moderate level of severity for the IG. No differences were observed for TMJ or for the masseter muscles PPT. CONCLUSION: Improvements were observed for visual analog scale scores and PPTs on temporal muscles. There was a group-by-time interaction in the IG, suggesting a possible potential use of DF for mouth opening.


Subject(s)
Facial Pain/therapy , Masticatory Muscles/physiopathology , Myalgia/therapy , Myofascial Pain Syndromes/therapy , Physical Therapy Modalities , Temporomandibular Joint Disorders/therapy , Temporomandibular Joint/physiopathology , Adult , Facial Pain/pathology , Facial Pain/physiopathology , Female , Humans , Mandible/pathology , Mandible/physiopathology , Massage , Masseter Muscle/pathology , Masseter Muscle/physiopathology , Masticatory Muscles/pathology , Mouth , Myalgia/physiopathology , Myofascial Pain Syndromes/physiopathology , Pain Measurement , Pain Threshold , Severity of Illness Index , Temporal Muscle/pathology , Temporal Muscle/physiopathology , Temporomandibular Joint/pathology , Temporomandibular Joint Disorders/pathology , Temporomandibular Joint Disorders/physiopathology , Treatment Outcome , Young Adult
6.
PLoS One ; 15(4): e0231734, 2020.
Article in English | MEDLINE | ID: mdl-32294140

ABSTRACT

Osteoarthritis is a degenerative disease that causes substantial changes in joint tissues, such as cartilage degeneration and subchondral bone sclerosis. Chondroitin sulfate and glucosamine are commonly used products for the symptomatic treatment of osteoarthritis. The aim of the present study was to investigate the effects of these products when used as structure-modifying drugs on the progression of osteoarthritis in the rabbit temporomandibular joint. Thirty-six New Zealand rabbits were divided into 3 groups (n = 12/group): control (no disease); osteoarthritis (disease induction); and treatment (disease induction and administration of chondroitin sulfate and glucosamine). Osteoarthritis was induced by intra-articular injection of monosodium iodoacetate. Animals were killed at 30 and 90 days after initiation of therapy. The treatment was effective in reducing disease severity, with late effects and changes in the concentration of glycosaminoglycans in the articular disc. The results indicate that chondroitin sulfate and glucosamine may have a structure-modifying effect on the tissues of rabbit temporomandibular joints altered by osteoarthritis.


Subject(s)
Arthritis, Experimental/drug therapy , Chondroitin Sulfates/administration & dosage , Glucosamine/administration & dosage , Osteoarthritis/drug therapy , Temporomandibular Joint/drug effects , Animals , Arthritis, Experimental/chemically induced , Arthritis, Experimental/diagnosis , Arthritis, Experimental/pathology , Cartilage, Articular/cytology , Cartilage, Articular/drug effects , Cartilage, Articular/pathology , Disease Models, Animal , Drug Therapy, Combination/methods , Extracellular Matrix/drug effects , Extracellular Matrix/pathology , Humans , Injections, Intra-Articular , Injections, Subcutaneous , Iodoacetic Acid/administration & dosage , Iodoacetic Acid/toxicity , Male , Osteoarthritis/chemically induced , Osteoarthritis/diagnosis , Osteoarthritis/pathology , Rabbits , Severity of Illness Index , Temporomandibular Joint/pathology
7.
Lasers Med Sci ; 35(2): 447-453, 2020 Mar.
Article in English | MEDLINE | ID: mdl-31292820

ABSTRACT

This study analyzed the effects of photobiomodulation (PBM) with low-level laser therapy on nociceptive behavior and neuronal activity in the trigeminal nucleus after experimental unilateral temporomandibular joint (TMJ) disc injury. The animals were divided into 4 groups (n = 10 each): group 1, surgical injury of the articular disc and PBM; group 2, sham-operated subjected to PBM; group 3, surgical injury of the articular disc; and group 4, control (Naïve). Ten sessions of PBM were performed using GaAs laser with a wavelength of 904 nm, power of 75 W pico, average power of 0.043 W, area of the beam of 0.13 cm2, duration of the pulses of 60 nseg (in the frequency of 9500 Hz), energy density of 5.95 J/cm2, energy per point of 0.7 J, and power density of 333.8 mW/cm2, and the irradiation was done for 18 s per point. Neuropathic symptoms were evaluated using the von Frey test. Trigeminal ganglion samples underwent immunoblotting to examine the expression of substance P, vanilloid transient potential receptor of subtype-1 (TRPV-1), and peptide related to the calcitonin gene (CGRP). There was a total decrease in pain sensitivity after the second session of PBM in operated animals, and this decrease remains until the last session. There was a significant decrease in the expression of SP, TRPV-1, and CGRP after PBM. Photobiomodulation therapy was effective in reducing nociceptive behavior and trigeminal nucleus neuronal activity after TMJ disc injury.


Subject(s)
Low-Level Light Therapy , Neuropeptides/metabolism , Pain Threshold , Pain/radiotherapy , Temporomandibular Joint/pathology , Temporomandibular Joint/radiation effects , Animals , Behavior, Animal , Calcitonin Gene-Related Peptide/metabolism , Lasers, Semiconductor , Male , Rats, Wistar , Substance P/metabolism , TRPV Cation Channels/metabolism , Treatment Outcome
8.
Lasers Med Sci ; 35(5): 1129-1139, 2020 Jul.
Article in English | MEDLINE | ID: mdl-31834562

ABSTRACT

This study aimed to investigate the anti-inflammatory effects of different dosage of low-level laser therapy (LLLT) in an experimental model of temporomandibular joint (TMJ) arthritis. One hundred male Wistar rats were used and divided into the following groups: CG, control group; AG, animals group with left TMJ arthritis induced by intra-articular injection of Complete Freund's adjuvant - CFA; LG5, LG10 and LG20 - animals with arthritis and treated with LLLT at doses 5, 10, and 20 J/cm2, respectively. Morphological analysis was performed by TMJ histological sections stained with hematoxylin-eosin (HE), picrosirius (PSR), and toluidine blue (TB), as well as histomorphometric evaluation of cartilage, articular disc, and masticatory muscles. The amount of feed consumed within 3 weeks was evaluated, and biochemical analysis of TMJ tissues included measurement of sulfated glycosaminoglycans (GAGs), matrix metalloproteinases (MMPs) 2 and 9 zymography, and ELISA for cytokines IL-6, TNF-α, and IL-1ß. Only the 20 J/cm2 dose promoted higher feed intake compared to AG. On the other hand, all LLLT doses promoted better organization of articular disc collagen fibers, greater number of proteoglycans in articular cartilage, increased area and diameter of left lateral pterygoid fibers, reduced latent and active MMP 9 and 2 activity, and lower IL-1ß concentration compared to AG. Considering the study limitations, it was observed that LLLT treatments were effective in protecting and tissue cleansing joint structures, accelerating tissue repair, especially at lower doses.


Subject(s)
Arthritis/radiotherapy , Low-Level Light Therapy , Masticatory Muscles/radiation effects , Temporomandibular Joint/radiation effects , Animals , Arthritis/pathology , Cartilage, Articular/pathology , Cartilage, Articular/radiation effects , Disease Models, Animal , Freund's Adjuvant/therapeutic use , Glycosaminoglycans/metabolism , Injections, Intra-Articular , Interleukin-1beta/metabolism , Interleukin-6/metabolism , Male , Masticatory Muscles/pathology , Proteoglycans/metabolism , Rats, Wistar , Temporomandibular Joint/pathology , Tumor Necrosis Factor-alpha/metabolism
9.
Braz Oral Res ; 32: e90, 2018 Aug 13.
Article in English | MEDLINE | ID: mdl-30110088

ABSTRACT

The aim of this study was to evaluate the biostimulation (BS) effect of the gallium-aluminum-arsenide (GaAlAs) diode laser by histopathology with an experimental osteoarthritis (OA) model in the temporomandibular joints (TMJ) of rabbits, in the early period. GaAlAs diode laser is used for pain reduction in TMJ disorders. Twenty-four adult male New Zealand white rabbits were randomly divided into three equal groups: Control Group (CG), Study Group 1 (SG-1), and Study Group 2 (SG-2). Mono-iodoacetate (MIA) was administered to the right TMJs of all rabbits. The rabbits did not undergo any treatment for four weeks to allow the development of osteoarthritis. In SG-1, laser BS was applied to the rabbits at 940 nm, 5 W, and 15 J/cm2 in continuous wave mode at 48-hour intervals for 14 sessions; and in SG-2, laser BS was applied with the same parameters at 24-hour intervals for 28 sessions. Laser BS was not applied to the rabbits in CG. All rabbits were sacrificed simultaneously. The TMJ cartilage, osteochondral junction, chondrocyte appearance, and subchondral ossification were evaluated histopathologically. There was no statistically significant difference between the groups in terms of cartilage, osteochondral junction, chondrocyte appearance, and subchondral ossification values (p > 0.05). The laser BS protocol used in the study had no positive histopathological effects on TMJ OA in the early period.


Subject(s)
Lasers, Semiconductor/therapeutic use , Low-Level Light Therapy/methods , Osteoarthritis/radiotherapy , Temporomandibular Joint Disorders/radiotherapy , Animals , Chondrocytes/pathology , Chondrocytes/radiation effects , Male , Osteoarthritis/pathology , Rabbits , Reproducibility of Results , Temporomandibular Joint/pathology , Temporomandibular Joint Disorders/pathology , Treatment Outcome
10.
Biomed Pharmacother ; 97: 1575-1585, 2018 Jan.
Article in English | MEDLINE | ID: mdl-29793320

ABSTRACT

Mimosa tenuiflora (Willd.) Poiret, popularly known in Brazil as "jurema-preta" is widely used against bronchitis, fever, headache and inflammation. Its antioxidant, anti-inflammatory and antinociceptive potential has already been reported. To assess the orofacial antinociceptive effect of M. tenuiflora, ethanolic extracts of M. tenuiflora (leaves, twigs, barks and roots) were submitted to in vitro tests of antioxidant activity. The extract with the highest antioxidant potential was partitioned and subjected to preliminary chemical prospecting, GC-MS, measurement of phenolic content and cytotoxicity tests of the fraction with the highest antioxidant activity. The nontoxic fraction with the highest antioxidant activity (FATEM) was subjected to tests of acute and chronic orofacial nociception and locomotor activity. The possible mechanisms of neuromodulation were also assessed. The EtOAc fraction, obtained from the ethanolic extract of M. tenuiflora barks, was the one with the highest antioxidant potential and nontoxic (FATEM), and Benzyloxyamine was the major constituent (34.27%). FATEM did not alter the locomotor system of mice and reduced significantly the orofacial nociceptive behavior induced by formalin, glutamate, capsaicin, cinnamaldehyde or acidic saline compared to the control group. FATEM also inhibited formalin- or mustard oil-induced temporomandibular nociception. In addition, it also reduced mustard oil-induced orofacial muscle nociception. However, FATEM did not alter hypertonic saline-induced corneal nociception. Neuropathic nociception was reversed by treatment with FATEM. The antinociceptive effect of FATEM was inhibited by naloxone, L-NAME and glibenclamide. FATEM has pharmacological potential for the treatment of acute and neuropathic orofacial pain and this effect is modulated by the opioid system, nitric oxide and ATP-sensitive potassium channels. These results lead us to studies of isolation and characterization of bioactive principles.


Subject(s)
Analgesics/therapeutic use , Facial Pain/drug therapy , Mimosa/chemistry , Nociception , Plant Extracts/therapeutic use , Acrolein/analogs & derivatives , Analgesics/pharmacology , Animals , Antioxidants/metabolism , Capsaicin , Chemical Fractionation , Chlorocebus aethiops , Ethanol , Facial Pain/pathology , Glutamic Acid , Glyburide/pharmacology , Glyburide/therapeutic use , Mice , Motor Activity/drug effects , NG-Nitroarginine Methyl Ester/pharmacology , NG-Nitroarginine Methyl Ester/therapeutic use , Naloxone/pharmacology , Naloxone/therapeutic use , Nociception/drug effects , Phenols/analysis , Plant Extracts/pharmacology , Rats, Wistar , Temporomandibular Joint/drug effects , Temporomandibular Joint/pathology , Vero Cells
11.
Bone ; 111: 9-22, 2018 06.
Article in English | MEDLINE | ID: mdl-29530720

ABSTRACT

The striking predilection of temporomandibular disorders (TMD) in women, especially during gonad-intact puberty or reproductive years, indicates that oestrogen plays an important role in the progression of TMD, but the underlying mechanism remains unclear. In this study, unilateral anterior crossbite (UAC) was used to create temporomandibular joint osteoarthritis (TMJ OA) models in rats, while 17ß-estradiol (E2) injections were applied to mimic patients with high-physiological levels of oestrogen. Micro-CT scanning, histological staining and real-time PCR assays were preformed to observe the degenerative changes in the mandibular condylar cartilage and subchondral bone. The results showed that obvious degradation was found in the condylar cartilage and subchondral bone of rats with UAC procedure, including decreased cartilage thickness, loss of extracellular matrix, increased apoptotic chondrocytes and expression of pro-inflammatory and catabolic factors, decreased bone mineral density and increased osteoclast activity. E2 supplements aggravated the condylar cartilage degradation but reversed the abnormal bone resorption in the subchondral bone induced by UAC. Our results revealed that high-physiological oestrogen plays a destructive role in condylar cartilage but a protective role in subchondral bone at the early stage of TMJ OA. These dual and distinct effects should be given serious consideration in future OA treatments.


Subject(s)
Bone Resorption/pathology , Cartilage, Articular/pathology , Estrogens/physiology , Mandibular Condyle/pathology , Osteoarthritis/pathology , Temporomandibular Joint Disorders/pathology , Animals , Bone Density/drug effects , Bone Resorption/drug therapy , Cartilage, Articular/drug effects , Chondrocytes/metabolism , Disease Models, Animal , Estrogens/administration & dosage , Estrogens/pharmacology , Female , Mandibular Condyle/drug effects , Osteoclasts/metabolism , Rats , Rats, Sprague-Dawley , Temporomandibular Joint/pathology , X-Ray Microtomography/methods
12.
Physiol Behav ; 188: 128-133, 2018 05 01.
Article in English | MEDLINE | ID: mdl-29425970

ABSTRACT

Hydrogen sulfide (H2S) is an endogenous neuromodulator produced mainly by the enzyme cystathionine gamma-lyase (CSE) in peripheral tissues. A pronociceptive role of endogenously produced H2S has been previously reported by our group in a model of orofacial inflammatory pain. Using the established persistent orofacial pain rat model induced by complete Freund's adjuvant (CFA) injection into temporomandibular joint (TMJ), we have now investigated the putative role of endogenous H2S modulating hypernociceptive responses. Additionally, plasmatic extravasation on TMJ was measured following different treatments by Evans blue dye quantification. Thus, rats were submitted to Von Frey and Formalin tests in orofacial region before and after pharmacological inhibition of the CSE-H2S system combined or not with CFA-induced TMJ inflammation. Pretreatment with CSE inhibitor, propargylglycine (PAG; 88.4 µmol/kg) reduced temporomandibular inflammatory pain when injected locally as well as systemically. In particular, local PAG injection seems to be more effective for hypernociceptive responses in orofacial persistent inflammation since its action is evidenced in the majority analyzed periods of the inflammatory process compared to its systemic use. Moreover, local injection seems to act on temporomandibular vascular permeability, evidenced by decreased plasmatic extravasation induced by local PAG administration. Our data are consistent with the notion that the endogenous synthetized gas H2S modulates persistent orofacial pain responses revealing the pharmacological importance of the CSE inhibitor as a possible therapeutic target for their control.


Subject(s)
Cystathionine gamma-Lyase/metabolism , Facial Pain/enzymology , Facial Pain/etiology , Inflammation/complications , Inflammation/pathology , Temporomandibular Joint/pathology , Alkynes/therapeutic use , Analysis of Variance , Animals , Enzyme Inhibitors/therapeutic use , Facial Pain/complications , Facial Pain/drug therapy , Freund's Adjuvant/toxicity , Glycine/analogs & derivatives , Glycine/therapeutic use , Hyperalgesia/drug therapy , Hyperalgesia/etiology , Inflammation/chemically induced , Male , Pain Measurement , Rats , Rats, Wistar , Time Factors , Treatment Outcome
13.
Dent Med Probl ; 55(4): 359-366, 2018.
Article in English | MEDLINE | ID: mdl-30648360

ABSTRACT

BACKGROUND: Osteoarthritis (OA) is a serious degenerative joint disease. It is one of the main causes of disability in the world. Current treatment modalities have numerous side effects. Subsequently, health experts are looking for alternative therapies. OBJECTIVES: The aim of the study was to evaluate the early effects of low-level laser therapy (LLLT) vs intraarticular (IA) corticosteroids (CS) on acute temporomandibular joint osteoarthritis (TMJOA). MATERIAL AND METHODS: Sixty rats were divided into 3 groups: group 1- untreated OA; group 2 - OA treated with CS; and group 3 - OA treated with LLL. Half of the animals in each group were sacrificed at 1 and 4 weeks post treatment. The temporomandibular joint was dissected and evaluated histochemically, using quantitative real-time polymerase chain reaction (qRT-PCR), and radiographically. RESULTS: Histochemically, Safranin-O staining revealed an obvious reduction in proteoglycans in the untreated osteoarthritic group. However, both of the treated groups showed a moderate increase in glycosaminoglycan (GAG) staining. As for the qRT-PCR results, caspase-3 showed the highest mean value in the untreated OA group, followed by the CS group, while the lowest mean value was recorded in the LLL group. Radiographically, the condyle showed erosion, flattening, osteophyte formation, and sclerosis in the untreated group, but there was great improvement in both of the treated groups. CONCLUSIONS: Both laser and cortisone showed reparative and formative effects, as evidenced by the increases in the proteoglycan content. However, LLL was superior in its anti-apoptotic effects. Cone beam computed tomography (CBCT) is a valuable tool in assessing osseous abnormalities.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Dexamethasone/therapeutic use , Low-Level Light Therapy , Osteoarthritis/drug therapy , Osteoarthritis/radiotherapy , Temporomandibular Joint Disorders/drug therapy , Temporomandibular Joint Disorders/radiotherapy , Animals , Anti-Inflammatory Agents/administration & dosage , Caspase 3/metabolism , Cone-Beam Computed Tomography , Dexamethasone/administration & dosage , Disease Models, Animal , Female , Injections, Intra-Articular , Low-Level Light Therapy/methods , Osteoarthritis/diagnostic imaging , Osteoarthritis/pathology , Rats , Real-Time Polymerase Chain Reaction , Temporomandibular Joint/diagnostic imaging , Temporomandibular Joint/pathology , Temporomandibular Joint Disorders/diagnostic imaging , Temporomandibular Joint Disorders/pathology
14.
Braz. oral res. (Online) ; 32: e90, 2018. tab, graf
Article in English | LILACS | ID: biblio-952149

ABSTRACT

Abstract The aim of this study was to evaluate the biostimulation (BS) effect of the gallium-aluminum-arsenide (GaAlAs) diode laser by histopathology with an experimental osteoarthritis (OA) model in the temporomandibular joints (TMJ) of rabbits, in the early period. GaAlAs diode laser is used for pain reduction in TMJ disorders. Twenty-four adult male New Zealand white rabbits were randomly divided into three equal groups: Control Group (CG), Study Group 1 (SG-1), and Study Group 2 (SG-2). Mono-iodoacetate (MIA) was administered to the right TMJs of all rabbits. The rabbits did not undergo any treatment for four weeks to allow the development of osteoarthritis. In SG-1, laser BS was applied to the rabbits at 940 nm, 5 W, and 15 J/cm2 in continuous wave mode at 48-hour intervals for 14 sessions; and in SG-2, laser BS was applied with the same parameters at 24-hour intervals for 28 sessions. Laser BS was not applied to the rabbits in CG. All rabbits were sacrificed simultaneously. The TMJ cartilage, osteochondral junction, chondrocyte appearance, and subchondral ossification were evaluated histopathologically. There was no statistically significant difference between the groups in terms of cartilage, osteochondral junction, chondrocyte appearance, and subchondral ossification values (p > 0.05). The laser BS protocol used in the study had no positive histopathological effects on TMJ OA in the early period.


Subject(s)
Animals , Male , Osteoarthritis/radiotherapy , Temporomandibular Joint Disorders/radiotherapy , Low-Level Light Therapy/methods , Lasers, Semiconductor/therapeutic use , Osteoarthritis/pathology , Rabbits , Temporomandibular Joint/pathology , Temporomandibular Joint Disorders/pathology , Reproducibility of Results , Treatment Outcome , Chondrocytes/radiation effects , Chondrocytes/pathology
15.
Arthritis Res Ther ; 17: 267, 2015 Sep 24.
Article in English | MEDLINE | ID: mdl-26400235

ABSTRACT

INTRODUCTION: Juvenile idiopathic arthritis (JIA) often causes inflammation of the temporomandibular joint (TMJ) and has been treated with both systemic and intra-articular steroids, with concerns about effects on growing bones. In this study, we evaluated the impact of a macromolecular prodrug of dexamethasone (P-DEX) with inflammation-targeting potential applied systemically or directly to the TMJ. METHODS: Joint inflammation was initiated by injecting two doses of complete Freund's adjuvant (CFA) at 1-month intervals into the right TMJs of 24 growing Sprague-Dawley male rats (controls on left side). Four additional rats were not manipulated. With the second CFA injection, animals received (1) 5 mg of P-DEX intra-articularly (n = 9), (2) 15 mg of P-DEX into the tail vein (n = 7), or (3) nothing in addition to CFA (n = 8). The rats were killed 28 days later and measured by radiography for ramus height (condylar superior to gonion inferior [CsGoInf]), by micro-computed tomography for condylar width (CW) and bone volume/standardized condylar volume (BV/CV), and by histology for retrodiscal inflammatory cells. Inflammation targeting of systemic P-DEX was confirmed by IVIS infrared dye imaging. Inflammation and bone growth were compared between groups using analysis of variance and Pearson's correlations. RESULTS: CFA caused a significant reduction in CsGoInf (p < 0.05), but neither route of P-DEX administration had an effect on CsGoInf or CW at CFA injection sites. BV/CV was significantly reduced in both inflamed and control condyles as a result of either steroid application (p < 0.05). The inflammatory infiltrate was overwhelmingly lymphocytic, comprising 16.4 ± 1.3 % of the field in CFA alone vs. <0.01 % lymphocytes in contralateral controls (p < 0.0001). Both P-DEX TMJ (10.1 ± 1.2 %) and systemic P-DEX (8.9 ± 1.7 %) reduced lymphocytes (p < 0.002). The total area of inflammatory infiltrate was significantly less in the systemic injection group than in the group that received CFA injections alone (2.6 ± 1.5 mm(2) vs. 8.0 ± 1.3 mm(2); p = 0.009), but not in the group that received intra-articular P-DEX (8.8 ± 1.2 mm(2)). CONCLUSIONS: High-dose systemic administration of inflammation-targeting P-DEX is more effective than an intra-articular injection in reducing TMJ inflammation, but both routes may affect TMJ bone density.


Subject(s)
Anti-Inflammatory Agents/administration & dosage , Arthritis, Experimental/pathology , Arthritis, Juvenile/pathology , Dexamethasone/administration & dosage , Prodrugs/administration & dosage , Temporomandibular Joint Disorders/pathology , Animals , Anti-Inflammatory Agents/adverse effects , Arthritis, Experimental/complications , Arthritis, Juvenile/complications , Bone Density/drug effects , Dexamethasone/adverse effects , Injections, Intra-Articular , Injections, Intravenous , Prodrugs/adverse effects , Rats , Temporomandibular Joint/drug effects , Temporomandibular Joint/pathology , Temporomandibular Joint Disorders/etiology
16.
Mycopathologia ; 180(3-4): 257-64, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26105580

ABSTRACT

Scedosporium apiospermum is an ubiquitous fungus responsible for various infections in immunocompromised and immunocompetent patients. Ear infections are infrequent. We report an exceptional case of S. apiospermum external otitis complicated by temporomandibular joint arthritis. After 6 months of antibiotherapy, diagnosis was established by mycological analysis of external auditory canal and infratemporal fossae needle sampling. A satisfactory outcome was obtained after 2 months of voriconazole alone. We have reviewed 15 cases of S. apiospermum otitis. Seven of these patients were immunocompromised. Most common clinical presentation included a chronic external otitis lasting months or years before complication stage. Most common clinical features included recurrent unilateral otalgia (11/15) and purulent otorrhea (13/15). Diagnosis was often made at later stage (12/15) with local extension to bones and/or soft tissues (9/15) or cerebral lethal dissemination (3/15).The extremely low incidence of S. apiospermum otomycosis and its non-specific presentation results in a frequent diagnosis delay. A mycological investigation should be performed in case of persistent external otitis and/or osteolysis despite prolonged antibiotic treatment to prevent further extension of the disease.


Subject(s)
Arthritis/etiology , Mycoses/diagnosis , Otitis Externa/diagnosis , Scedosporium/isolation & purification , Temporomandibular Joint Disorders/diagnosis , Aged, 80 and over , Antifungal Agents/therapeutic use , Arthritis/microbiology , Arthritis/pathology , Head/diagnostic imaging , Humans , Male , Mycoses/microbiology , Mycoses/pathology , Otitis Externa/complications , Otitis Externa/microbiology , Temporomandibular Joint/pathology , Temporomandibular Joint Disorders/microbiology , Temporomandibular Joint Disorders/pathology , Tomography, X-Ray Computed , Treatment Outcome , Voriconazole/therapeutic use
17.
Rev. Asoc. Odontol. Argent ; 103(2): 94-99, jun. 2015. tab, ilus
Article in Spanish | LILACS | ID: lil-762466

ABSTRACT

La artritis reumatoidea juvenil (ARJ) es una enfermedad inflamatoria autoinmune en niños menores de 16 años. Es de curso crónico, etiología desconocida y afecta sobre todo las articulaciones, como la temporomandibular (ATM). El compromiso de la ATM puede ocasionar alteraciones en el crecimiento facial (micrognatia), maloclusión clase II, mordida abierta anterior, desviaciones laterales, erosiones óseas, destrucción del cóndilo, oclusión disfuncional y alteración de la estética facial, entre otras consecuencias. La posición oclusal neurofisiológica lograda por medio de elementos electrónicos, como el Transcutaneous Electrical Neural Stimulation (TENS), y mantenida por el dispositivo intraoral (DIO), posibilitaría la remodelación de la cabeza del cóndilo, en pacientes en crecimiento, en los que la enfermedad se halla controlada, controlando así también la sintomatología dolorosa.


Subject(s)
Humans , Male , Female , Child , Adolescent , Young Adult , Jaw Abnormalities/etiology , Temporomandibular Joint/pathology , Arthritis, Juvenile/complications , Anti-Inflammatory Agents , Arthritis, Juvenile/classification , Clinical Protocols , Diagnosis, Differential , Magnetic Resonance Imaging , Patient Care Team , Physical Therapy Specialty , Transcutaneous Electric Nerve Stimulation
18.
Rev. Asoc. Odontol. Argent ; 103(2): 94-99, jun. 2015. tab, ilus
Article in Spanish | BINACIS | ID: bin-133820

ABSTRACT

La artritis reumatoidea juvenil (ARJ) es una enfermedad inflamatoria autoinmune en niños menores de 16 años. Es de curso crónico, etiología desconocida y afecta sobre todo las articulaciones, como la temporomandibular (ATM). El compromiso de la ATM puede ocasionar alteraciones en el crecimiento facial (micrognatia), maloclusión clase II, mordida abierta anterior, desviaciones laterales, erosiones óseas, destrucción del cóndilo, oclusión disfuncional y alteración de la estética facial, entre otras consecuencias. La posición oclusal neurofisiológica lograda por medio de elementos electrónicos, como el Transcutaneous Electrical Neural Stimulation (TENS), y mantenida por el dispositivo intraoral (DIO), posibilitaría la remodelación de la cabeza del cóndilo, en pacientes en crecimiento, en los que la enfermedad se halla controlada, controlando así también la sintomatología dolorosa. (AU)


Subject(s)
Humans , Male , Female , Child , Adolescent , Young Adult , Jaw Abnormalities/etiology , Arthritis, Juvenile/complications , Temporomandibular Joint/pathology , Arthritis, Juvenile/classification , Physical Therapy Modalities , Diagnosis, Differential , Anti-Inflammatory Agents/therapeutic use , Magnetic Resonance Imaging , Clinical Protocols , Patient Care Team , Transcutaneous Electric Nerve Stimulation
19.
Lasers Med Sci ; 30(8): 2105-13, 2015 Nov.
Article in English | MEDLINE | ID: mdl-25854994

ABSTRACT

Temporomandibular disorders (TMDs) are mostly inflammatory conditions widespread in the population. Previous studies have shown positive effects of either laser or light-emitting diode (LED) phototherapies on treating TMDs, but their action and mechanism in the inflammatory infiltrate of the temporomandibular joint are still poorly understood. The aim of this study was to assess, through histological analysis, the effectiveness of using laser light (λ 780 nm, 70 mW, continous wave (CW), 10 J) and LED (λ 850 ± 10 nm, 100 mW, CW, 10 J) on the inflammation of the temporomandibular joint of rats induced by carrageenan. Forty-five animals were divided into three groups with five animals each according to the experimental times of 2, 3, and 7 days: inflammation, inflammation+laser phototherapy, and inflammation+LED phototherapy. The first irradiation was performed 24 h after induction with an interval of 48 h between sessions. After animal death, specimens were processed and stained with hematoxylin-eosin (HE) and picrosirius. Then, the samples were examined histologically. Data were statistically analyzed. The inflammation group showed mild to moderate chronic inflammatory infiltrate between bone trabecules of the condyle. Over the time course of the study in the laser group, the region of the condyle presented mild chronic inflammation and intense vascularization. In the LED group, the condyle showed aspects of normality and absence of inflammation in some specimens. In all the time points, the laser-irradiated groups showed greater amount of collagen deposition in the condyle (p = 0.04) and in the disc (p = 0.03) when compared to the inflammation and LED groups, respectively. Laser- and LED-treated groups demonstrate a smaller number of layers of the synovial membrane when compared to the non-irradiated groups. It was concluded that, in general, laser and LED phototherapies resulted in a reduction of inflammatory infiltrate in the temporomandibular joint of rat.


Subject(s)
Inflammation/pathology , Lasers , Low-Level Light Therapy/methods , Temporomandibular Joint/pathology , Temporomandibular Joint/radiation effects , Animals , Carrageenan , Collagen/metabolism , Male , Neovascularization, Physiologic , Rats, Wistar
20.
J Immunol ; 194(6): 2810-8, 2015 Mar 15.
Article in English | MEDLINE | ID: mdl-25681337

ABSTRACT

Macrophages play a major role in joint inflammation. Estrogen is involved in rheumatoid arthritis and temporomandibular disorders. However, the underlying mechanism is still unclear. This study was done to verify and test how estrogen affects M1/M2-like macrophage polarization and then contributes to joint inflammation. Female rats were ovariectomized and treated with increasing doses of 17ß-estradiol for 10 d and then intra-articularly injected with CFA to induce temporomandibular joint (TMJ) inflammation. The polarization of macrophages and expression of cadherin-11 was evaluated at 24 h after the induction of TMJ inflammation and after blocking cadherin-11 or estrogen receptors. NR8383 macrophages were treated with estradiol and TNF-α, with or without blocking cadherin-11 or estrogen receptors, to evaluate the expression of the M1/M2-like macrophage-associated genes. We found that estradiol increased the infiltration of macrophages with a proinflammatory M1-like predominant profile in the synovium of inflamed TMJ. In addition, estradiol dose-dependently upregulated the expressions of the M1-associated proinflammatory factor inducible NO synthase (iNOS) but repressed the expressions of the M2-associated genes IL-10 and arginase in NR8383 macrophages. Furthermore, estradiol mainly promoted cadherin-11 expression in M1-like macrophages of inflamed TMJ. By contrast, blockage of cadherin-11 concurrently reversed estradiol-potentiated M1-like macrophage activation and TMJ inflammation, as well as reversed TNF-α-induced induction of inducible NO synthase and NO in NR8383 macrophages. The blocking of estrogen receptors reversed estradiol-potentiated M1-like macrophage activation and cadherin-11 expression. These results suggested that estradiol could promote M1-like macrophage activation through cadherin-11 to aggravate the acute inflammation of TMJs.


Subject(s)
Cadherins/immunology , Estradiol/immunology , Inflammation/immunology , Macrophage Activation/immunology , Macrophages/immunology , Temporomandibular Joint/immunology , Animals , Arginase/genetics , Arginase/immunology , Arginase/metabolism , Arthritis/genetics , Arthritis/immunology , Arthritis/metabolism , Blotting, Western , Cadherins/genetics , Cadherins/metabolism , Estradiol/analogs & derivatives , Estradiol/pharmacology , Estrogen Receptor Antagonists/pharmacology , Estrogens/immunology , Estrogens/pharmacology , Female , Fulvestrant , Gene Expression/drug effects , Gene Expression/immunology , Inflammation/genetics , Inflammation/metabolism , Interleukin-10/genetics , Interleukin-10/immunology , Interleukin-10/metabolism , Macrophage Activation/drug effects , Macrophages/drug effects , Macrophages/metabolism , Microscopy, Confocal , Nitric Oxide/immunology , Nitric Oxide/metabolism , Nitric Oxide Synthase Type II/genetics , Nitric Oxide Synthase Type II/immunology , Nitric Oxide Synthase Type II/metabolism , Ovariectomy , Rats, Sprague-Dawley , Receptors, Estrogen/antagonists & inhibitors , Receptors, Estrogen/immunology , Receptors, Estrogen/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Temporomandibular Joint/drug effects , Temporomandibular Joint/pathology , Tumor Necrosis Factor-alpha/immunology , Tumor Necrosis Factor-alpha/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL